9 employees
Immunostep is a biotechnology company that develops flow chemistry products for diagnostic and research applications.
2000
$1.3M
from 1 investors over 1 rounds
Immunostep raised $1.3M on May 26, 2016
Investors: ALENTIA CAPITAL ALTERNATIVO